HEADER HYDROLASE/HYDROLASE INHIBITOR 09-DEC-21 7T42 TITLE STRUCTURE OF SARS-COV-2 3CL PROTEASE IN COMPLEX WITH INHIBITOR 2C COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 3CL-PRO, 3CLP, MAIN PROTEASE, MPRO, NON-STRUCTURAL PROTEIN COMPND 5 5, NSP5, SARS CORONAVIRUS MAIN PROTEINASE; COMPND 6 EC: 3.4.22.69; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 GENE: REP, 1A-1B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS COVID-19, PROTEASE, SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2, KEYWDS 2 SARS-COV-2 3CL PROTEASE INHHIBITORS, HYDROLASE, HYDROLASE-HYDROLASE KEYWDS 3 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR L.LIU,S.LOVELL,K.P.BATTAILE,S.D.CHAMANDI,Y.KIM,W.C.GROUTAS,K.O.CHANG REVDAT 6 23-OCT-24 7T42 1 REMARK REVDAT 5 18-OCT-23 7T42 1 REMARK REVDAT 4 22-JUN-22 7T42 1 JRNL REVDAT 3 15-JUN-22 7T42 1 JRNL REVDAT 2 08-JUN-22 7T42 1 JRNL REVDAT 1 22-DEC-21 7T42 0 JRNL AUTH C.S.DAMPALLA,A.D.RATHNAYAKE,A.C.GALASITI KANKANAMALAGE, JRNL AUTH 2 Y.KIM,K.D.PERERA,H.N.NGUYEN,M.J.MILLER,T.K.MADDEN, JRNL AUTH 3 H.R.PICARD,H.A.THURMAN,M.M.KASHIPATHY,L.LIU,K.P.BATTAILE, JRNL AUTH 4 S.LOVELL,K.O.CHANG,W.C.GROUTAS JRNL TITL STRUCTURE-GUIDED DESIGN OF POTENT SPIROCYCLIC INHIBITORS OF JRNL TITL 2 SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 3C-LIKE JRNL TITL 3 PROTEASE. JRNL REF J.MED.CHEM. V. 65 7818 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 35638577 JRNL DOI 10.1021/ACS.JMEDCHEM.2C00224 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_4302 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.97 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 78302 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 3681 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.9700 - 4.7400 0.99 2922 153 0.1609 0.1918 REMARK 3 2 4.7400 - 3.7600 1.00 2874 159 0.1365 0.1590 REMARK 3 3 3.7600 - 3.2900 1.00 2869 153 0.1656 0.1870 REMARK 3 4 3.2900 - 2.9900 1.00 2882 153 0.1811 0.2267 REMARK 3 5 2.9900 - 2.7700 1.00 2872 143 0.1865 0.2193 REMARK 3 6 2.7700 - 2.6100 1.00 2906 138 0.1872 0.2399 REMARK 3 7 2.6100 - 2.4800 0.99 2883 112 0.1865 0.2111 REMARK 3 8 2.4800 - 2.3700 1.00 2886 129 0.1815 0.2189 REMARK 3 9 2.3700 - 2.2800 1.00 2897 123 0.1823 0.2163 REMARK 3 10 2.2800 - 2.2000 1.00 2880 121 0.1900 0.2468 REMARK 3 11 2.2000 - 2.1300 1.00 2849 169 0.1902 0.2119 REMARK 3 12 2.1300 - 2.0700 1.00 2895 145 0.1866 0.2413 REMARK 3 13 2.0700 - 2.0200 1.00 2832 160 0.1948 0.2339 REMARK 3 14 2.0200 - 1.9700 1.00 2835 156 0.1907 0.2006 REMARK 3 15 1.9700 - 1.9200 1.00 2884 135 0.2008 0.2664 REMARK 3 16 1.9200 - 1.8800 1.00 2896 143 0.2123 0.2616 REMARK 3 17 1.8800 - 1.8400 1.00 2845 137 0.2098 0.2278 REMARK 3 18 1.8400 - 1.8100 0.99 2868 155 0.2114 0.2405 REMARK 3 19 1.8100 - 1.7800 0.99 2815 140 0.2153 0.2515 REMARK 3 20 1.7800 - 1.7500 0.99 2893 135 0.2244 0.2644 REMARK 3 21 1.7500 - 1.7200 0.99 2825 142 0.2279 0.2610 REMARK 3 22 1.7200 - 1.6900 0.99 2880 144 0.2371 0.2492 REMARK 3 23 1.6900 - 1.6700 1.00 2841 138 0.2465 0.2828 REMARK 3 24 1.6700 - 1.6400 0.99 2842 135 0.2545 0.3069 REMARK 3 25 1.6400 - 1.6200 0.99 2867 131 0.2634 0.3267 REMARK 3 26 1.6200 - 1.6000 0.99 2883 132 0.2711 0.2915 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.180 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.430 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.74 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.85 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7T42 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-DEC-21. REMARK 100 THE DEPOSITION ID IS D_1000261583. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JUL-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS-II REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.7 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 78397 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 49.280 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : 0.08800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.63 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 6.90 REMARK 200 R MERGE FOR SHELL (I) : 1.11000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6XMK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% (W/V) PEG 1500, 100 MM PCTP, PH REMARK 280 5.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 49.28450 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2170 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A -3 REMARK 465 ASN A -2 REMARK 465 ILE A -1 REMARK 465 GLY A 0 REMARK 465 SER A 1 REMARK 465 GLY A 2 REMARK 465 SER A 301 REMARK 465 GLY A 302 REMARK 465 VAL A 303 REMARK 465 THR A 304 REMARK 465 PHE A 305 REMARK 465 SER B -3 REMARK 465 ASN B -2 REMARK 465 ILE B -1 REMARK 465 GLY B 0 REMARK 465 SER B 1 REMARK 465 VAL B 303 REMARK 465 THR B 304 REMARK 465 PHE B 305 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 4 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 47 CG CD OE1 OE2 REMARK 470 ASN A 72 CG OD1 ND2 REMARK 470 GLN A 74 CG CD OE1 NE2 REMARK 470 ARG A 76 CD NE CZ NH1 NH2 REMARK 470 LYS A 90 NZ REMARK 470 LYS A 97 CE NZ REMARK 470 LYS A 100 CE NZ REMARK 470 LYS A 102 CG CD CE NZ REMARK 470 ASP A 153 CG OD1 OD2 REMARK 470 TYR A 154 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP A 155 CG OD1 OD2 REMARK 470 ARG A 222 CD NE CZ NH1 NH2 REMARK 470 PHE A 223 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 240 CD OE1 OE2 REMARK 470 ARG A 279 CD NE CZ NH1 NH2 REMARK 470 ARG A 298 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 50 CG CD1 CD2 REMARK 470 GLU B 55 CG CD OE1 OE2 REMARK 470 ARG B 76 CD NE CZ NH1 NH2 REMARK 470 LYS B 100 CD CE NZ REMARK 470 LYS B 102 CE NZ REMARK 470 ASP B 153 CG OD1 OD2 REMARK 470 TYR B 154 CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP B 155 CG OD1 OD2 REMARK 470 ARG B 222 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 236 CD CE NZ REMARK 470 GLU B 290 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -125.56 54.73 REMARK 500 ASN A 84 -123.95 51.42 REMARK 500 TYR A 154 -130.52 64.92 REMARK 500 PRO A 184 33.48 -88.87 REMARK 500 ARG A 217 17.71 -155.51 REMARK 500 ASP B 33 -130.07 54.41 REMARK 500 ASN B 51 84.63 -155.64 REMARK 500 ASN B 84 -120.08 51.58 REMARK 500 TYR B 154 -116.02 61.66 REMARK 500 ARG B 217 24.96 -141.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 FIK A 501 REMARK 610 FIW A 502 REMARK 610 FIK B 403 REMARK 610 FIW B 404 DBREF 7T42 A 1 305 UNP P0DTD1 R1AB_SARS2 3264 3568 DBREF 7T42 B 1 305 UNP P0DTD1 R1AB_SARS2 3264 3568 SEQADV 7T42 SER A -3 UNP P0DTD1 EXPRESSION TAG SEQADV 7T42 ASN A -2 UNP P0DTD1 EXPRESSION TAG SEQADV 7T42 ILE A -1 UNP P0DTD1 EXPRESSION TAG SEQADV 7T42 GLY A 0 UNP P0DTD1 EXPRESSION TAG SEQADV 7T42 SER B -3 UNP P0DTD1 EXPRESSION TAG SEQADV 7T42 ASN B -2 UNP P0DTD1 EXPRESSION TAG SEQADV 7T42 ILE B -1 UNP P0DTD1 EXPRESSION TAG SEQADV 7T42 GLY B 0 UNP P0DTD1 EXPRESSION TAG SEQRES 1 A 309 SER ASN ILE GLY SER GLY PHE ARG LYS MET ALA PHE PRO SEQRES 2 A 309 SER GLY LYS VAL GLU GLY CYS MET VAL GLN VAL THR CYS SEQRES 3 A 309 GLY THR THR THR LEU ASN GLY LEU TRP LEU ASP ASP VAL SEQRES 4 A 309 VAL TYR CYS PRO ARG HIS VAL ILE CYS THR SER GLU ASP SEQRES 5 A 309 MET LEU ASN PRO ASN TYR GLU ASP LEU LEU ILE ARG LYS SEQRES 6 A 309 SER ASN HIS ASN PHE LEU VAL GLN ALA GLY ASN VAL GLN SEQRES 7 A 309 LEU ARG VAL ILE GLY HIS SER MET GLN ASN CYS VAL LEU SEQRES 8 A 309 LYS LEU LYS VAL ASP THR ALA ASN PRO LYS THR PRO LYS SEQRES 9 A 309 TYR LYS PHE VAL ARG ILE GLN PRO GLY GLN THR PHE SER SEQRES 10 A 309 VAL LEU ALA CYS TYR ASN GLY SER PRO SER GLY VAL TYR SEQRES 11 A 309 GLN CYS ALA MET ARG PRO ASN PHE THR ILE LYS GLY SER SEQRES 12 A 309 PHE LEU ASN GLY SER CYS GLY SER VAL GLY PHE ASN ILE SEQRES 13 A 309 ASP TYR ASP CYS VAL SER PHE CYS TYR MET HIS HIS MET SEQRES 14 A 309 GLU LEU PRO THR GLY VAL HIS ALA GLY THR ASP LEU GLU SEQRES 15 A 309 GLY ASN PHE TYR GLY PRO PHE VAL ASP ARG GLN THR ALA SEQRES 16 A 309 GLN ALA ALA GLY THR ASP THR THR ILE THR VAL ASN VAL SEQRES 17 A 309 LEU ALA TRP LEU TYR ALA ALA VAL ILE ASN GLY ASP ARG SEQRES 18 A 309 TRP PHE LEU ASN ARG PHE THR THR THR LEU ASN ASP PHE SEQRES 19 A 309 ASN LEU VAL ALA MET LYS TYR ASN TYR GLU PRO LEU THR SEQRES 20 A 309 GLN ASP HIS VAL ASP ILE LEU GLY PRO LEU SER ALA GLN SEQRES 21 A 309 THR GLY ILE ALA VAL LEU ASP MET CYS ALA SER LEU LYS SEQRES 22 A 309 GLU LEU LEU GLN ASN GLY MET ASN GLY ARG THR ILE LEU SEQRES 23 A 309 GLY SER ALA LEU LEU GLU ASP GLU PHE THR PRO PHE ASP SEQRES 24 A 309 VAL VAL ARG GLN CYS SER GLY VAL THR PHE SEQRES 1 B 309 SER ASN ILE GLY SER GLY PHE ARG LYS MET ALA PHE PRO SEQRES 2 B 309 SER GLY LYS VAL GLU GLY CYS MET VAL GLN VAL THR CYS SEQRES 3 B 309 GLY THR THR THR LEU ASN GLY LEU TRP LEU ASP ASP VAL SEQRES 4 B 309 VAL TYR CYS PRO ARG HIS VAL ILE CYS THR SER GLU ASP SEQRES 5 B 309 MET LEU ASN PRO ASN TYR GLU ASP LEU LEU ILE ARG LYS SEQRES 6 B 309 SER ASN HIS ASN PHE LEU VAL GLN ALA GLY ASN VAL GLN SEQRES 7 B 309 LEU ARG VAL ILE GLY HIS SER MET GLN ASN CYS VAL LEU SEQRES 8 B 309 LYS LEU LYS VAL ASP THR ALA ASN PRO LYS THR PRO LYS SEQRES 9 B 309 TYR LYS PHE VAL ARG ILE GLN PRO GLY GLN THR PHE SER SEQRES 10 B 309 VAL LEU ALA CYS TYR ASN GLY SER PRO SER GLY VAL TYR SEQRES 11 B 309 GLN CYS ALA MET ARG PRO ASN PHE THR ILE LYS GLY SER SEQRES 12 B 309 PHE LEU ASN GLY SER CYS GLY SER VAL GLY PHE ASN ILE SEQRES 13 B 309 ASP TYR ASP CYS VAL SER PHE CYS TYR MET HIS HIS MET SEQRES 14 B 309 GLU LEU PRO THR GLY VAL HIS ALA GLY THR ASP LEU GLU SEQRES 15 B 309 GLY ASN PHE TYR GLY PRO PHE VAL ASP ARG GLN THR ALA SEQRES 16 B 309 GLN ALA ALA GLY THR ASP THR THR ILE THR VAL ASN VAL SEQRES 17 B 309 LEU ALA TRP LEU TYR ALA ALA VAL ILE ASN GLY ASP ARG SEQRES 18 B 309 TRP PHE LEU ASN ARG PHE THR THR THR LEU ASN ASP PHE SEQRES 19 B 309 ASN LEU VAL ALA MET LYS TYR ASN TYR GLU PRO LEU THR SEQRES 20 B 309 GLN ASP HIS VAL ASP ILE LEU GLY PRO LEU SER ALA GLN SEQRES 21 B 309 THR GLY ILE ALA VAL LEU ASP MET CYS ALA SER LEU LYS SEQRES 22 B 309 GLU LEU LEU GLN ASN GLY MET ASN GLY ARG THR ILE LEU SEQRES 23 B 309 GLY SER ALA LEU LEU GLU ASP GLU PHE THR PRO PHE ASP SEQRES 24 B 309 VAL VAL ARG GLN CYS SER GLY VAL THR PHE HET FIK A 501 32 HET FIW A 502 32 HET PG4 B 401 13 HET PG4 B 402 13 HET FIK B 403 29 HET FIW B 404 29 HETNAM FIK (1S,2S)-2-[(N-{[(2-ACETYL-2-AZASPIRO[3.3]HEPTAN-6-YL) HETNAM 2 FIK OXY]CARBONYL}-L-LEUCYL)AMINO]-1-HYDROXY-3-[(3S)-2- HETNAM 3 FIK OXOPYRROLIDIN-3-YL]PROPANE-1-SULFONIC ACID HETNAM FIW (1R,2S)-1-HYDROXY-2-{[N-({[2-(2-METHYLPROPANOYL)-2- HETNAM 2 FIW AZASPIRO[3.3]HEPTAN-6-YL]OXY}CARBONYL)-L- HETNAM 3 FIW LEUCYL]AMINO}-3-[(3S)-2-OXOPYRROLIDIN-3-YL]PROPANE-1- HETNAM 4 FIW SULFONIC ACID HETNAM PG4 TETRAETHYLENE GLYCOL FORMUL 3 FIK 2(C24 H40 N4 O9 S) FORMUL 4 FIW 2(C24 H40 N4 O9 S) FORMUL 5 PG4 2(C8 H18 O5) FORMUL 9 HOH *257(H2 O) HELIX 1 AA1 SER A 10 GLY A 15 1 6 HELIX 2 AA2 HIS A 41 CYS A 44 5 4 HELIX 3 AA3 ASN A 53 ARG A 60 1 8 HELIX 4 AA4 SER A 62 PHE A 66 5 5 HELIX 5 AA5 ILE A 200 ASN A 214 1 15 HELIX 6 AA6 THR A 226 TYR A 237 1 12 HELIX 7 AA7 THR A 243 LEU A 250 1 8 HELIX 8 AA8 LEU A 250 GLY A 258 1 9 HELIX 9 AA9 ALA A 260 GLY A 275 1 16 HELIX 10 AB1 THR A 292 CYS A 300 1 9 HELIX 11 AB2 SER B 10 GLY B 15 1 6 HELIX 12 AB3 HIS B 41 CYS B 44 5 4 HELIX 13 AB4 THR B 45 MET B 49 5 5 HELIX 14 AB5 ASN B 53 ARG B 60 1 8 HELIX 15 AB6 SER B 62 PHE B 66 5 5 HELIX 16 AB7 ILE B 200 ASN B 214 1 15 HELIX 17 AB8 THR B 226 TYR B 237 1 12 HELIX 18 AB9 THR B 243 LEU B 250 1 8 HELIX 19 AC1 LEU B 250 GLY B 258 1 9 HELIX 20 AC2 ALA B 260 GLY B 275 1 16 HELIX 21 AC3 THR B 292 GLY B 302 1 11 SHEET 1 AA1 7 VAL A 73 LEU A 75 0 SHEET 2 AA1 7 LEU A 67 ALA A 70 -1 N VAL A 68 O LEU A 75 SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N THR A 21 O LEU A 67 SHEET 4 AA1 7 THR A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 AA1 7 VAL A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 6 AA1 7 VAL A 86 VAL A 91 -1 O LEU A 87 N CYS A 38 SHEET 7 AA1 7 VAL A 77 GLN A 83 -1 N SER A 81 O LYS A 88 SHEET 1 AA2 5 LYS A 100 PHE A 103 0 SHEET 2 AA2 5 CYS A 156 GLU A 166 1 O VAL A 157 N LYS A 100 SHEET 3 AA2 5 VAL A 148 ASP A 153 -1 N ASN A 151 O SER A 158 SHEET 4 AA2 5 THR A 111 TYR A 118 -1 N SER A 113 O PHE A 150 SHEET 5 AA2 5 SER A 121 ALA A 129 -1 O TYR A 126 N VAL A 114 SHEET 1 AA3 3 LYS A 100 PHE A 103 0 SHEET 2 AA3 3 CYS A 156 GLU A 166 1 O VAL A 157 N LYS A 100 SHEET 3 AA3 3 HIS A 172 THR A 175 -1 O ALA A 173 N MET A 165 SHEET 1 AA4 7 VAL B 73 LEU B 75 0 SHEET 2 AA4 7 LEU B 67 ALA B 70 -1 N VAL B 68 O LEU B 75 SHEET 3 AA4 7 MET B 17 CYS B 22 -1 N THR B 21 O LEU B 67 SHEET 4 AA4 7 THR B 25 LEU B 32 -1 O LEU B 27 N VAL B 20 SHEET 5 AA4 7 VAL B 35 PRO B 39 -1 O VAL B 35 N LEU B 32 SHEET 6 AA4 7 VAL B 86 VAL B 91 -1 O LEU B 87 N CYS B 38 SHEET 7 AA4 7 VAL B 77 GLN B 83 -1 N ILE B 78 O LYS B 90 SHEET 1 AA5 5 LYS B 100 PHE B 103 0 SHEET 2 AA5 5 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 AA5 5 VAL B 148 ASP B 153 -1 N ASN B 151 O SER B 158 SHEET 4 AA5 5 THR B 111 TYR B 118 -1 N SER B 113 O PHE B 150 SHEET 5 AA5 5 SER B 121 ALA B 129 -1 O SER B 123 N ALA B 116 SHEET 1 AA6 3 LYS B 100 PHE B 103 0 SHEET 2 AA6 3 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 AA6 3 HIS B 172 THR B 175 -1 O ALA B 173 N MET B 165 LINK SG CYS A 145 C19AFIK A 501 1555 1555 1.81 LINK SG CYS A 145 C19BFIW A 502 1555 1555 1.80 LINK SG CYS B 145 C19AFIK B 403 1555 1555 1.81 LINK SG CYS B 145 C19BFIW B 404 1555 1555 1.80 CRYST1 55.102 98.569 58.691 90.00 107.72 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018148 0.000000 0.005797 0.00000 SCALE2 0.000000 0.010145 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017887 0.00000